Drug Rhythm-Control Failure Widens Opening For Ablation, Say Cardiologists

Drug-based rhythm-control therapy does not help keep patients with atrial fibrillation and heart failure alive any better than conventional heart failure drugs, researchers report in the June 19 New England Journal of Medicine

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight